MarketsandMarkets is hosting an inaugural Microbiome - Advanced Therapeutics and Sequencing Congress on September 19 - 20 2019 in Philadelphia, USA gathering pharma, biotech, academicians and investors to exchange views and observe most ingenious microbiome research and technologies.
Over the two days, the congress will address:
Major breakthroughs of microbial research and applications
Challenges associated with medicinal data interpretation, investments and regulatory hurdles
Detection of non-identified dysbiosis to discover potential research areas with increasing investments in gut and skin microbiome
The four-session agenda will also address key aspects such as non-bacterial component, microbiome in clinical applications, preventative medicines and diagnostics gathering leading microbiome companies working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies.
Microbial Innovations, Gut and Skin Microbiota, Regulatory Issues, Next-Generation Sequencing, Gut-Brain Axis
Professionals working on Microbiome discovery, Microbiome science, Human microbiome, Drug Microbiome discovery & Immunotherapy, Microbiology, Microbiome therapeutics
Please contact us on email@example.com to get hotel booking link.
For any queries regarding the hotel booking please write to us at firstname.lastname@example.org
Hotel Booking Link
You will receive a link to book your accommodation via email once you are fully registered. (Please note that we do not authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on email@example.com